Your browser doesn't support javascript.
loading
Case report: A mesenchymal chondrosarcoma with alternative HEY1::NCOA2 fusions in the sella turcica.
Kishikawa, Satsuki; Kondo, Akihide; Yao, Takashi; Saito, Tsuyoshi.
Afiliação
  • Kishikawa S; Department of Human Pathology, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
  • Kondo A; Department of Neurosurgery, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
  • Yao T; Department of Human Pathology, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
  • Saito T; Department of Human Pathology, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
Pathol Oncol Res ; 30: 1611730, 2024.
Article em En | MEDLINE | ID: mdl-39165647
ABSTRACT

Introduction:

Mesenchymal chondrosarcoma (MCS) is a rare subtype of chondrosarcoma that occurs at widespread anatomical locations, such as bone, soft tissue, and intracranial sites. The central nervous system (CNS) is one of the most common origins of extraosseous MCS. However, alternative HEY1NCOA2 fusions have not been reported in this tumor. Case report We report a case of intracranial MCS with HEY1NCOA2 rearrangement. A 52-year-old woman presented with a 15-mm calcified mass around the sella turcica. She initially underwent transsphenoidal surgery for tumor resection and then additional resections for five local recurrences over 5 years. Histologically, the tumor was composed of small round to spindle-shaped cells admixed with well-differentiated hyaline cartilaginous islands. A hemangiopericytoma-like vascular pattern and small sinusoid-like vessels were also observed. RNA sequencing using RNA extracted from formalin-fixed paraffin-embedded samples from the last operation revealed two alternative variants of the HEY1NCOA2 fusion HEY1(ex4)NCOA2 (ex13) and HEY1(ex4)NCOA2(ex14). Both variants were confirmed as in-frame fusions using reverse transcription-polymerase chain reaction.

Discussion:

Cartilaginous components were often not apparent during the recurrences. In addition to the non-typical pathological finding, the correct diagnosis was hampered by the poor RNA quality of the surgical specimens and non-specific STAT6 nuclear staining.

Conclusion:

This is the first reported case of intracranial MCS with an alternative HEY1NCOA2 fusion.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sela Túrcica / Condrossarcoma Mesenquimal / Proteínas de Ciclo Celular / Fatores de Transcrição Hélice-Alça-Hélice Básicos / Coativador 2 de Receptor Nuclear Limite: Female / Humans / Middle aged Idioma: En Revista: Pathol Oncol Res / Pathol. oncol. res / Pathology oncology research Assunto da revista: NEOPLASIAS / PATOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sela Túrcica / Condrossarcoma Mesenquimal / Proteínas de Ciclo Celular / Fatores de Transcrição Hélice-Alça-Hélice Básicos / Coativador 2 de Receptor Nuclear Limite: Female / Humans / Middle aged Idioma: En Revista: Pathol Oncol Res / Pathol. oncol. res / Pathology oncology research Assunto da revista: NEOPLASIAS / PATOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão País de publicação: Suíça